Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
28.89%
↑ 141% above average
Average (34q)
-70.50%
Historical baseline
Range
High:161.34%
Low:-1528.64%
Volatility
-2397.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 28.89% |
| Q2 2025 | -33.97% |
| Q1 2025 | -75.66% |
| Q4 2024 | -294.33% |
| Q3 2024 | -72.91% |
| Q2 2024 | 134.66% |
| Q1 2024 | -1528.64% |
| Q4 2023 | -40.01% |
| Q3 2023 | 116.83% |
| Q2 2023 | -51.27% |
| Q1 2023 | 161.34% |
| Q4 2022 | -11.01% |
| Q3 2022 | 6.99% |
| Q2 2022 | 3.25% |
| Q1 2022 | -25.39% |
| Q4 2021 | -10.38% |
| Q3 2021 | 20.98% |
| Q2 2021 | -18.49% |
| Q1 2021 | 14.64% |
| Q4 2020 | 3.81% |
| Q3 2020 | 5.43% |
| Q2 2020 | 15.63% |
| Q1 2020 | -17.56% |
| Q4 2019 | 15.83% |
| Q3 2019 | -4.27% |
| Q2 2019 | 1.40% |
| Q1 2019 | 1.66% |
| Q4 2018 | -48.12% |
| Q3 2018 | -11.45% |
| Q2 2018 | -721.28% |
| Q1 2018 | 84.41% |
| Q4 2017 | 22.88% |
| Q3 2017 | -216.69% |
| Q2 2017 | 75.34% |
| Q1 2017 | 0.00% |